Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FQ64E
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,577
Award facts
- Contract value 100% obligated
- $14,576.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $14,576.99 by the Defense Logistics Agency on August 12, 2025, for the supply of Nucala 100 mg/ml auto-injectors. The contract, which carries no set-aside designation, is scheduled for completion by August 13, 2025, with performance to be fulfilled at the contractor's Park Ridge facility. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that authorizes firm fixed-price delivery orders for comprehensive pharmaceutical products supporting Department of Defense medical supply requirements.
The Defense Logistics Agency utilizes the SPE2DB indefinite delivery contract vehicle to procure a broad portfolio of pharmaceutical items, including branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables in various delivery formats such as injections, tablets, and auto-injectors. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing delivery orders for specialty medications and medical products distributed to military health facilities nationwide. The company's woman-owned small business status has enabled it to compete effectively in federal procurement markets while maintaining a robust contract portfolio that demonstrates its capability to deliver specialized pharmaceutical products to government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQ64E?
SPE2DB25FQ64E was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FQ64E worth?
The government has obligated $14,577 on SPE2DB25FQ64E.
Is contract SPE2DB25FQ64E an order under another contract?
Yes. SPE2DB25FQ64E is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB25FQ64E competed?
The extent of competition for SPE2DB25FQ64E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award